Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 3 study of Staccato alprazolam for prolonged stereotyped seizure episodes in patients aged 12 years and older
CTR20220334Phase 3Active
- Sponsor
- UCB
- Start
- Nov 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in epilepsy and seizure disorder comparing Staccato alprazolam with Placebo (2 arms). Started Nov 2022; status: active.
02
Drugs
alprazolam
03
Conditions
epilepsyseizure disorder
Beyond the preview
Go deeper on CTR20220334.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20220334.